[LXRX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -7.63%
YoY- -0.02%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 7,999 9,216 25,207 18,293 12,494 1,792 277 75.06%
PBT -66,611 -21,797 -42,075 -43,543 -34,883 -28,076 -30,835 13.68%
Tax 958 789 6,119 -8,652 1,128 1,347 543 9.91%
NP -66,611 -21,797 -42,075 -34,891 -34,883 -28,076 -30,835 13.68%
Tax Rate - - - - - - - -
Total Cost 74,610 31,013 67,282 53,184 47,377 29,868 31,112 15.67%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -832.74 -236.51 -166.92 -190.73 -279.20 -1,566.74 -11,131.77 -35.06%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.63 -0.21 -0.40 -0.33 -0.34 -0.27 -0.42 6.98%
EPS Diluted -0.63 -0.21 -0.40 -0.33 -0.34 -0.27 -0.42 6.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.